An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/7CDCC2F0.svg?ark=w1%2F20260515%2F7CDCC2F0)](https://nobleid.org/work/w1/20260515/7CDCC2F0)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors